2009
DOI: 10.1016/j.biocel.2008.11.004
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Hexadecylphosphocholine alters nonvesicular cholesterol traffic from the plasma membrane to the endoplasmic reticulum and inhibits the synthesis of sphingomyelin in HepG2 cells

Search citation statements

Order By: Relevance

Paper Sections

Select...
25
4
2
2

Citation Types

4
22
0
1

Year Published

Range
2010
2010
2025
2025

Publication Types

Select...
22
3
2
2

Relationship

3
26

Authors

Journals

citations

Cited by 29 publications

(27 citation statements)
references

References 34 publications

4
22
0
1
Order By: Relevance
How this paper cites the one you are viewing
“…For instance, the decrease of SM content after treatment with IC75 EPC3 was ~24% for MCF-7 cells and ~16% for MDA-MB-231 cells as compared with the control samples. This finding is in line with the observations of Marco and coworkers [47] who showed that treatment of human hepatoma HepG2 cell line with Miltefosine led to inhibition of SM metabolism. Disturbances in SM synthesis could cause the accumulation of ceramide and sphingosine, which regulate cellular functions such as proliferation, gene expression, differentiation, mitosis, cell survival, and apoptosis.…”
Section: Epc3 Treatment Alters Phospholipid and Cholesterol Contents In Cell Membranes
supporting
confidence: 92%